ARCHIVES

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

This article is from The Cancer Letter archive.

Vol. 06 No. 35 | September 5, 1980

Download PDF Visit The Full Archive

Related Articles

Report Backs EPA Classification of PERC as Likely Human Carcinogen

February 12, 2010

ORI Progress On Fisher Case Questioned; Panel Not Formed

March 3, 1995

In Brief: Mauer Resigns St. Jude Director; Breslow Named DRCCA Board Chairman; Senate Considers Line Items

August 20, 1982

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

In Brief: Schilsky Succeeds McIntyre As CALB Chair; UC Irvine Awarded New Cancer Center Grants

November 11, 1994